Legal & General Group
VRTX icon

Legal & General Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$841M Sell
1,889,777
-4,392
-0.2% -$1.96M 0.21% 89
2025
Q1
$918M Buy
1,894,169
+10,016
+0.5% +$4.86M 0.25% 74
2024
Q4
$759M Sell
1,884,153
-21,159
-1% -$8.52M 0.2% 86
2024
Q3
$886M Sell
1,905,312
-67,063
-3% -$31.2M 0.23% 73
2024
Q2
$924M Sell
1,972,375
-53,291
-3% -$25M 0.26% 62
2024
Q1
$847M Sell
2,025,666
-35,939
-2% -$15M 0.24% 73
2023
Q4
$839M Buy
2,061,605
+21,247
+1% +$8.65M 0.26% 68
2023
Q3
$710M Sell
2,040,358
-88,561
-4% -$30.8M 0.25% 72
2023
Q2
$749M Buy
2,128,919
+42,588
+2% +$15M 0.24% 77
2023
Q1
$657M Buy
2,086,331
+52,967
+3% +$16.7M 0.24% 88
2022
Q4
$587M Sell
2,033,364
-104,734
-5% -$30.2M 0.23% 98
2022
Q3
$619M Sell
2,138,098
-62,651
-3% -$18.1M 0.24% 83
2022
Q2
$620M Buy
2,200,749
+143,620
+7% +$40.5M 0.22% 94
2022
Q1
$537M Buy
2,057,129
+158,485
+8% +$41.4M 0.16% 124
2021
Q4
$417M Sell
1,898,644
-169,690
-8% -$37.3M 0.13% 176
2021
Q3
$375M Buy
2,068,334
+119,277
+6% +$21.6M 0.12% 180
2021
Q2
$393M Buy
1,949,057
+240,660
+14% +$48.5M 0.13% 166
2021
Q1
$367M Sell
1,708,397
-11,931
-0.7% -$2.56M 0.14% 162
2020
Q4
$407M Buy
1,720,328
+34,424
+2% +$8.14M 0.16% 134
2020
Q3
$459M Buy
1,685,904
+47,162
+3% +$12.8M 0.21% 96
2020
Q2
$476M Buy
1,638,742
+53,940
+3% +$15.7M 0.23% 81
2020
Q1
$377M Buy
1,584,802
+66,406
+4% +$15.8M 0.22% 96
2019
Q4
$332M Buy
1,518,396
+55,481
+4% +$12.1M 0.16% 139
2019
Q3
$248M Buy
1,462,915
+3,297
+0.2% +$559K 0.13% 195
2019
Q2
$268M Buy
1,459,618
+8,308
+0.6% +$1.52M 0.14% 165
2019
Q1
$267M Buy
1,451,310
+297,731
+26% +$54.8M 0.15% 153
2018
Q4
$191M Buy
1,153,579
+79,216
+7% +$13.1M 0.15% 160
2018
Q3
$207M Buy
1,074,363
+20,630
+2% +$3.98M 0.15% 159
2018
Q2
$179M Sell
1,053,733
-43,434
-4% -$7.38M 0.14% 176
2018
Q1
$179M Sell
1,097,167
-53,915
-5% -$8.79M 0.14% 176
2017
Q4
$173M Sell
1,151,082
-26,186
-2% -$3.92M 0.12% 192
2017
Q3
$179M Buy
1,177,268
+36,305
+3% +$5.52M 0.13% 186
2017
Q2
$147M Buy
1,140,963
+53,020
+5% +$6.83M 0.12% 204
2017
Q1
$119M Buy
1,087,943
+39,469
+4% +$4.32M 0.1% 230
2016
Q4
$77.2M Buy
1,048,474
+10,839
+1% +$799K 0.07% 302
2016
Q3
$90.5M Buy
1,037,635
+10,690
+1% +$932K 0.09% 248
2016
Q2
$88.3M Buy
1,026,945
+50,584
+5% +$4.35M 0.09% 252
2016
Q1
$77.6M Sell
976,361
-81
-0% -$6.44K 0.09% 261
2015
Q4
$123M Buy
976,442
+7,091
+0.7% +$892K 0.14% 167
2015
Q3
$101M Buy
969,351
+33,959
+4% +$3.54M 0.12% 195
2015
Q2
$116M Buy
935,392
+21,679
+2% +$2.68M 0.14% 182
2015
Q1
$108M Sell
913,713
-1,536
-0.2% -$181K 0.13% 193
2014
Q4
$109M Sell
915,249
-21,681
-2% -$2.58M 0.13% 198
2014
Q3
$105M Sell
936,930
-52,935
-5% -$5.95M 0.13% 193
2014
Q2
$93.7M Buy
989,865
+23,257
+2% +$2.2M 0.11% 225
2014
Q1
$68.4M Sell
966,608
-4,721
-0.5% -$334K 0.08% 270
2013
Q4
$72.2M Buy
971,329
+35,123
+4% +$2.61M 0.09% 257
2013
Q3
$71M Buy
936,206
+64,367
+7% +$4.88M 0.09% 248
2013
Q2
$69.6M Buy
+871,839
New +$69.6M 0.1% 242